Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Allogene Therapeutics at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Allogene Therapeutics brings 2 presentations to SITC 2026 in Phoenix. Its program focuses on allogeneic, off-the-shelf CAR T cell therapy. The most concrete topic is clinical experience from the TRAVERSE study of an allogeneic CAR T approach in renal cell carcinoma.

Organization

SITC 2026 Attendance

Allogene Therapeutics

South San Francisco, CA

Biotech

Clinical-stage company developing allogeneic, off-the-shelf CAR T cell therapies.

Talk

Thu Nov 5
9:05am–9:15am

Part of Session I: Cell Therapies and Technologies

Advancing a First-in-Class Allogeneic CAR T Approach in Renal Cell Carcinoma: Clinical Experience from the TRAVERSE Study

Valley of the Sun Ballroom

Cell therapy · Clinical

Talk

Fri Nov 6
4:25pm–4:40pm

Part of Session 107b: Biotech Session: The Next Generation of Off-the-Shelf IO

Allogeneic Cell Therapies

Cell therapy

Instantly find 20 buyers from Allogene Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction